Harriet Vogt
Members
-
Joined
-
Last visited
-
Content Article CommentAs always with the system there is a great deal of complexity. Maybe it would bring clarity to complexity if the focus started with the common major risk factor – changing/adding medications or changing dosage is always a high risk time for any patient. Even those being prescribed antidepressants by primary care. Why not think of building a simpler patient protective/monitoring process around that.
-
Content Article CommentIf correcting your records was such a struggle for you, as both HCP and patient – we can only imagine how opaque and difficult the process would be for patients. I think Helen H makes a subtle point – instinctively people tend to perceive the output of computer systems as ‘truth’. Nothing could be further from it.
-
-
Content Article
Post-SSRI Sexual Dysfunction (PSSD) is a long-term adverse effect of Selective Serotonin Reuptake Inhibitors (SSRIs), a type of antidepressant medication. In this opinion piece, Harriet Vogt, Patient Safety Partner at NHS Sussex Integrated Care Board, outlines the need for recognition and research into PSSD to allow patients to make truly informed choices when considering SSRIs. She looks at the impact PSSD has on the sexual and emotional lives of thousands of people and highlights a new research study analysing the obstacles to quantifying its incidence and prevalence. Harriet argues that while the health system is beginning to recognise the value of placing patients at the heart of efforts to improve safety, this focus on listening is rarely given to individual patients who express concern about the impact of their medication or treatment.
